Literature DB >> 17362924

Plasma and CNS concentrations of Gaboxadol in rats following subcutaneous administration.

Thomas Cremers1, Bjarke Ebert.   

Abstract

Gaboxadol has been suggested to be a selective extrasynaptic GABA(A) receptor agonist. However, there is little information on Gaboxadol concentrations in the central nervous system (CNS) at therapeutically relevant doses. In order to investigate this, rats were injected subcutaneously with Gaboxadol and plasma and CNS concentrations were determined using the dynamic-no-net-flux and ultraslow microdialysis methods. Results using the 2 methods were similar and showed that Gaboxadol rapidly entered the brain and that peak CNS concentrations after 2.5, 5 and 10 mg/kg were in the range of 0.7 to 3 microM. Furthermore, a very short half-life (28 min) in both plasma and CNS was observed. It is concluded that concentrations of Gaboxadol in the CNS are in a range, which are likely to activate only extrasynaptic (nongamma subunit containing) GABA(A) receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362924     DOI: 10.1016/j.ejphar.2007.01.017

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

1.  Effects of gaboxadol on the expression of cocaine sensitization in rats.

Authors:  Nora Siegal Silverman; Susanna Popp; Vincent Vialou; Konstantin Astafurov; Eric J Nestler; Diana Dow-Edwards
Journal:  Exp Clin Psychopharmacol       Date:  2016-02-22       Impact factor: 3.157

2.  The subcellular localization of GABA transporters and its implication for seizure management.

Authors:  Karsten K Madsen; Gert H Hansen; E Michael Danielsen; Arne Schousboe
Journal:  Neurochem Res       Date:  2014-12-18       Impact factor: 3.996

3.  Alteration of ethanol drinking in mice via modulation of the GABA(A) receptor with ganaxolone, finasteride, and gaboxadol.

Authors:  Marcia J Ramaker; Matthew M Ford; Andrea M Fretwell; Deborah A Finn
Journal:  Alcohol Clin Exp Res       Date:  2011-06-07       Impact factor: 3.455

4.  Effect of ganaxolone and THIP on operant and limited-access ethanol self-administration.

Authors:  Marcia J Ramaker; Moriah N Strong; Matthew M Ford; Deborah A Finn
Journal:  Neuropharmacology       Date:  2012-05-18       Impact factor: 5.250

5.  Selective GABA transporter inhibitors tiagabine and EF1502 exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA(A) receptor agonist gaboxadol.

Authors:  Karsten K Madsen; Bjarke Ebert; Rasmus P Clausen; Povl Krogsgaard-Larsen; Arne Schousboe; H Steve White
Journal:  J Pharmacol Exp Ther       Date:  2011-03-30       Impact factor: 4.030

6.  Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia.

Authors:  Trine Damgaard; Niels Plath; Jo C Neill; Suzanne L Hansen
Journal:  Psychopharmacology (Berl)       Date:  2010-10-19       Impact factor: 4.530

Review 7.  Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders.

Authors:  Daryl L Davies; Marco Bortolato; Deborah A Finn; Marcia J Ramaker; Segev Barak; Dorit Ron; Jing Liang; Richard W Olsen
Journal:  Alcohol Clin Exp Res       Date:  2012-06-04       Impact factor: 3.455

8.  Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol.

Authors:  M J Ramaker; M M Ford; T J Phillips; D A Finn
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

9.  Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transporters.

Authors:  Xiao-Yan Chu; Yuexia Liang; Xiaoxin Cai; Karla Cuevas-Licea; Ronda K Rippley; Kelem Kassahun; Magang Shou; Matthew P Braun; George A Doss; M Reza Anari; Raymond Evers
Journal:  Pharm Res       Date:  2008-12-11       Impact factor: 4.200

10.  Inhibition of thalamic excitability by 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-ol: a selective role for delta-GABA(A) receptors.

Authors:  Murray B Herd; Nicola Foister; Dev Chandra; Dianne R Peden; Gregg E Homanics; Verity J Brown; David J K Balfour; Jeremy J Lambert; Delia Belelli
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.